Search
Search Results
##search.searchResults.foundPlural##
-
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2823PDF: 1016HTML: 82 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7013PDF: 3706HTML: 808 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1370PDF: 1179HTML: 130 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2472PDF: 975HTML: 335 -
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3439PDF: 1506HTML: 4077 -
-
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3287PDF: 933HTML: 777text and figure: 241 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2308PDF: 1075HTML: 2023Characteristic of study group: 214 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2262PDF: 1454HTML: 898 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3711PDF: 1701HTML: 2687 -
-
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
466PDF: 466Suppl. Files: 63HTML: 142 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2855PDF: 786HTML: 1300Blood Count trend before and during lenalidomide treatment: 187Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 202 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2114PDF: 1073HTML: 15732COVER LETTER: 202 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1739PDF: 756HTML: 2349 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2926PDF: 1462HTML: 3088Cover Letter: 223 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
10318PDF: 1008HTML: 296 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5248PDF: 1361HTML: 2863Cover letter: 214 -
How I treat acute and persistent sickle cell pain
2030PDF: 1142HTML: 647 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2168PDF: 792HTML: 1074Spirometry in SCA patients before transplant: 218Spirometry in SCA patients post transplant: 193 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4084PDF: 1565HTML: 9246Untitled: 290Untitled: 198Untitled: 183Untitled: 176Untitled: 198Untitled: 355 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1440HTML: 625PDF: 862







